Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat

Olfactomedin 4 下调中性粒细胞对革兰氏阳性菌和革兰氏阴性菌的杀伤

基本信息

项目摘要

Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negative bacteria We recently demonstrated that OLFM4 negatively regulates host innate immunity against Helicobacter pylori. To extend our previous study, we determined whether OLFM4 might regulate innate immunity against broad bacteria infections by investigating the bactericidal activity in neutrophils from OLFM4-/- mice. In this study, we have demonstrated that OLFM4 is a novel neutrophil granule protein. Neutrophils from OLFM4-/- mice have increased intracellular killing of Staphlocococus aureus and Escherichia coli in vitro. The OLFM4-/- mice have enhanced in vivo bacteria clearance and are more resistant to sepsis when challenged with intra-peritoneal injection of S. aureus or E. coli. Using a yeast two hybridization assay, OLFM4 is found to interact with cathepsin C, a cysteine protease that pays an important role in the bacterial clearance and inflammatory response. We have demonstrated that OLFM4 is a direct substrate of cathepsin C and inhibits cathepsin C activity in vitro and in vivo. The cathepsin C activity in neutrophils from OLFM4-/- mice is significantly higher than that in neutrophils from wild-type littermate mice. The activities of serine proteinases, neutrophil elastase, cathepsin G and proteinase 3, whose processing and maturity require cathepsin C activity, are also higher in OLFM4-/- neutrophils. These results indicate that OLFM4 is an important negative regulator of neutrophil bactericidal activity against broad range of bacteria via restricting cathepsin C activity and its down stream granule-associated serine proteases. Olfactomedin 4 is a secreted antagonist of Wnt/β-catenin pathway OLFM4 is a secreted glycoprotein, but its effect on intracellular signal pathway has not been investigated. Previous studies have shown that members of olfactomedin family, olfactomedin 1 and myocillin are modulators of Wnt signaling pathways. Here we investigated whether OLFM4 can regulate Wnt pathway. To address this question, we treated 293T cells with purified OLFM4 protein. Downregulation of β-catenin protein levels were observed in total cell lysate and more obviously in subcellular fractions including cell membrane, cytoplasm and nucleus. The degradation of β-catenin was dependent on GSK3-mediated phosphorylation and go through proteasome mediated degradation. Overexpression of OLFM4 in 293T cells also decreased the β-catenin level. We have found exogenously added OLFM4 protein and overexpression of OLFM4 can antagonize Wnt3a induced upregulation of β-catenin in the cytoplasm and nucleus of 293T cells. Primary study demonstrated that OLFM4 might interact with Frizzled receptor in 293T cells. We have identified OLFM4 as an extracellular Wnt antagonist that inhibits Wnt signaling probably at the level of interaction with its surface receptors. OLFM4 may prove to be an effective therapeutic agent to interfere with Wnt pathway involving Wnts and their receptors.
嗅觉调节素4下调中性粒细胞对革兰氏阳性和革兰氏阴性细菌的杀伤作用 我们最近证实,OLFM4负性调节宿主对幽门螺杆菌的天然免疫。为了扩展我们之前的研究,我们通过研究OLFM4-/-鼠中性粒细胞的杀菌活性来确定OLFM4是否可能调节对广泛细菌感染的先天免疫。在本研究中,我们证明了OLFM4是一种新的中性粒细胞颗粒蛋白。来自OLFM4-/-小鼠的中性粒细胞在体外增加了对金黄色葡萄球菌和大肠杆菌的细胞内杀伤力。OLFM4-/-小鼠增强了体内细菌的清除,并在腹腔内注射金黄色葡萄球菌或大肠杆菌时对败血症具有更强的抵抗力。使用酵母双杂交试验,OLFM4被发现与组织蛋白酶C相互作用,组织蛋白酶C是一种半胱氨酸蛋白酶,在细菌清除和炎症反应中发挥重要作用。我们已经证明,OLFM4是组织蛋白酶C的直接底物,在体外和体内都能抑制组织蛋白酶C的活性。OLFM4-/-小鼠中性粒细胞的组织蛋白酶C活性显著高于野生型小鼠的中性粒细胞。在OLFM4-/-中性粒细胞中,丝氨酸蛋白酶、中性粒细胞弹性蛋白酶、组织蛋白酶G和蛋白酶3的活性也较高,这些酶的加工和成熟需要组织蛋白酶C的活性。这些结果表明,OLFM4通过限制组织蛋白酶C及其下游颗粒相关丝氨酸蛋白酶的活性,是中性粒细胞对多种细菌杀菌活性的重要负调控因子。 Ofactomedin 4是Wnt/-catenin途径的分泌型拮抗剂 Olfm4是一种分泌型糖蛋白,但其对细胞内信号通路的影响尚未被研究。以往的研究表明,olfactomedin家族成员、olfactomedin 1和myoclin是Wnt信号通路的调节者。在这里,我们研究了OLFM4是否能调节Wnt通路。为了解决这个问题,我们用纯化的OLFM4蛋白处理293T细胞。在总细胞裂解物中观察到连环素蛋白水平的下调,在包括细胞膜、细胞质和细胞核在内的亚细胞部分中更为明显。-连环蛋白的降解依赖于GSK3介导的磷酸化,并经历蛋白酶体介导的降解。在293T细胞中过表达OLFM4也降低了-连环蛋白水平。我们发现外源添加OLFM4蛋白和过表达OLFM4可以拮抗Wnt3a诱导的293T细胞胞浆和胞核中连环蛋白的上调。初步研究表明,OLFM4可能与293T细胞中的Frizzled型受体相互作用。我们已经确定OLFM4是一种细胞外Wnt拮抗剂,可能在与其表面受体相互作用的水平上抑制Wnt信号转导。Olfm4可能是一种有效的治疗药物,可以干扰涉及Wnts及其受体的Wnt途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GRIFFIN RODGERS其他文献

GRIFFIN RODGERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GRIFFIN RODGERS', 18)}}的其他基金

Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
  • 批准号:
    8939812
  • 财政年份:
  • 资助金额:
    $ 83.2万
  • 项目类别:
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
Olfactomedin 4 下调中性粒细胞对革兰氏阳性菌和革兰氏阴性菌的杀伤
  • 批准号:
    8557968
  • 财政年份:
  • 资助金额:
    $ 83.2万
  • 项目类别:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
与 GATA1 融合的重组红系 Kruppel 样因子上调珠蛋白 expr
  • 批准号:
    8557970
  • 财政年份:
  • 资助金额:
    $ 83.2万
  • 项目类别:
Glia maturation factor-gamma negatively modulates TLR4 signaling in macrophages
胶质细胞成熟因子-γ负调节巨噬细胞中的 TLR4 信号传导
  • 批准号:
    8149534
  • 财政年份:
  • 资助金额:
    $ 83.2万
  • 项目类别:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
与 GATA1 融合的重组红系 Kruppel 样因子上调珠蛋白 expr
  • 批准号:
    8149535
  • 财政年份:
  • 资助金额:
    $ 83.2万
  • 项目类别:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
  • 批准号:
    9157363
  • 财政年份:
  • 资助金额:
    $ 83.2万
  • 项目类别:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
Olfactomedin 4 通过 Negativ 抑制前列腺癌细胞的生长和转移
  • 批准号:
    8557967
  • 财政年份:
  • 资助金额:
    $ 83.2万
  • 项目类别:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
Olfactomedin 4 通过 Negativ 抑制前列腺癌细胞的生长和转移
  • 批准号:
    8939810
  • 财政年份:
  • 资助金额:
    $ 83.2万
  • 项目类别:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
  • 批准号:
    9357228
  • 财政年份:
  • 资助金额:
    $ 83.2万
  • 项目类别:
Olfactomedin 4 is a key regulator of human neutrophil function
Olfactomedin 4 是人类中性粒细胞功能的关键调节剂
  • 批准号:
    10012677
  • 财政年份:
  • 资助金额:
    $ 83.2万
  • 项目类别:

相似海外基金

Cerebral infarction treatment strategy using collagen-like "triple helix peptide" containing functional amino acid sequence
含功能氨基酸序列的类胶原“三螺旋肽”治疗脑梗塞策略
  • 批准号:
    23K06972
  • 财政年份:
    2023
  • 资助金额:
    $ 83.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a screening method for functional microproteins independent of amino acid sequence conservation
不依赖氨基酸序列保守性的功能性微生物蛋白筛选方法的建立
  • 批准号:
    23KJ0939
  • 财政年份:
    2023
  • 资助金额:
    $ 83.2万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Effects of amino acid sequence and lipids on the structure and self-association of transmembrane helices
氨基酸序列和脂质对跨膜螺旋结构和自缔合的影响
  • 批准号:
    19K07013
  • 财政年份:
    2019
  • 资助金额:
    $ 83.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Construction of electron-transfer amino acid sequence probe with an interaction for protein and cell
蛋白质与细胞相互作用的电子转移氨基酸序列探针的构建
  • 批准号:
    16K05820
  • 财政年份:
    2016
  • 资助金额:
    $ 83.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of artificial antibody of anti-bitter taste receptor using random amino acid sequence library
利用随机氨基酸序列库开发抗苦味受体人工抗体
  • 批准号:
    16K08426
  • 财政年份:
    2016
  • 资助金额:
    $ 83.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The aa15-17 amino acid sequence in the terminal protein domain of HBV polymerase as a viral factor affect-ing in vivo as well as in vitro replication activity of the virus.
HBV聚合酶末端蛋白结构域中的aa15-17氨基酸序列作为影响病毒体内和体外复制活性的病毒因子。
  • 批准号:
    25461010
  • 财政年份:
    2013
  • 资助金额:
    $ 83.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Amino acid sequence analysis of fossil proteins using mass spectrometry
使用质谱法分析化石蛋白质的氨基酸序列
  • 批准号:
    23654177
  • 财政年份:
    2011
  • 资助金额:
    $ 83.2万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Precise hybrid synthesis of glycoprotein through amino acid sequence-specific introduction of oligosaccharide followed by enzymatic transglycosylation reaction
通过氨基酸序列特异性引入寡糖,然后进行酶促糖基转移反应,精确杂合合成糖蛋白
  • 批准号:
    22550105
  • 财政年份:
    2010
  • 资助金额:
    $ 83.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Estimating selection on amino-acid sequence polymorphisms in Drosophila
果蝇氨基酸序列多态性选择的估计
  • 批准号:
    NE/D00232X/1
  • 财政年份:
    2006
  • 资助金额:
    $ 83.2万
  • 项目类别:
    Research Grant
Construction of a neural network for detecting novel domains from amino acid sequence information only
构建仅从氨基酸序列信息检测新结构域的神经网络
  • 批准号:
    16500189
  • 财政年份:
    2004
  • 资助金额:
    $ 83.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了